Company profile: Ology Bio
1.1 - Company Overview
Company description
- Provider of biologics CDMO services specializing in single-use processes and manufacturing up to BSL-3.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ology Bio
CenExel
HQ: United States
Website
- Description: Provider of clinical research site network services supporting phase I-IV clinical trials, offering medical and scientific services to assist in the design and execution of clinical studies. Operates multiple centers across the country, delivering comprehensive resources to enhance research outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CenExel company profile →
Enavate Sciences
HQ: United States
Website
- Description: Provider of capital and strategic growth support to therapeutic and enabling technology companies, partnering with life sciences companies and their investors to advance and accelerate the development of novel therapies and help companies realize their potential.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enavate Sciences company profile →
FIS
HQ: Italy
Website
- Description: Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and intermediates, supporting clients from development to commercial production. Offers generic API development and manufacturing, veterinary CDMO, and specialized sterile manufacturing, micronization, lyophilization, and spray drying. Produces 100+ APIs across anticancer, steroids, psychotropics, and veterinary classes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FIS company profile →
Pharmaloz
HQ: United States
Website
- Description: Provider of development, contract manufacturing, and packaging services for pharmaceutical, OTC, and dietary supplement products, specializing in lozenges. Offers private label programs; R&D for formulation, ingredient selection, and dose optimization; FDA-aligned quality and regulatory compliance; and packaging solutions including blistering, wrapping, and final packaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaloz company profile →
Biomind Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical development for neurological and psychiatric disorders, advancing candidates including BMND01 for treatment-resistant depression, BMND03 for addictive disorders, BMND07 for major depressive disorder, BMND09 for Parkinson’s disease, BMND08 for depression and anxiety in Alzheimer’s disease, and Triptax™, a new chemical entity for treatment-resistant depression with FDA IND clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomind Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ology Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ology Bio
2.2 - Growth funds investing in similar companies to Ology Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ology Bio
4.2 - Public trading comparable groups for Ology Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →